French Guiana Wellness Network: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on French Guiana Wellness Network.

Press releases published on August 24, 2026

Aug. 24, 2026

AEON Biopharma Designates Former FDA Neuroscience Leader Paul Lee, M.D., Ph.D. as Acting Chief Regulatory Officer

Indeterminate GlobeNewswire

Aug. 24, 2026

Erasca Granted FDA Fast Track Designation for Pan-RAS Molecular Glue ERAS-0015 in Patients with Metastatic Pancreatic Adenocarcinoma

Indeterminate GlobeNewswire

Aug. 24, 2026

Rhythm Pharmaceuticals Announces MHLW Approval of IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity (HO) in Japan

Indeterminate GlobeNewswire

Aug. 24, 2026

BridgeBio to Present New Acoramidis Data from Open-Label Extension Analyses in ATTR-CM at ESC Congress 2026

Indeterminate GlobeNewswire

Aug. 24, 2026

Arbutus Commences US$230 Million Modified “Dutch Auction” Tender Offer of its Common Shares at a Price Not Greater Than US$5.75 Nor Less Than US$5.00 Per Share

Indeterminate GlobeNewswire

Aug. 24, 2026

BriaCell Advances Personalized Melanoma Immunotherapy Vaccine Candidate, Bria-MEL+™

Indeterminate GlobeNewswire

Aug. 24, 2026

Kraig Biocraft Laboratories Boosts Spider Silk Output More Than 30% During the Most Technically Challenging Season of the Year

Indeterminate GlobeNewswire

Aug. 24, 2026

Felix Health launches sleep apnea care through new collaboration with MedSleep

Indeterminate GlobeNewswire

Aug. 24, 2026

VERAXA Biotech and Secarna Pharmaceuticals Achieve Research Milestone in Antibody Oligonucleotide Conjugate (AOC) Alliance

Indeterminate GlobeNewswire

Aug. 24, 2026

Monte Rosa Therapeutics Announces First Patient Dosed in MODeFIRe-1, a Phase 2 Study of MRT-2359 in Combination with Apalutamide in Patients with AR Mutation-Positive Metastatic Castration-Resistant Prostate Cancer

Indeterminate GlobeNewswire

Aug. 24, 2026

Rapport Therapeutics to Host Virtual KOL Event on the Unmet Need in Bipolar Mania and the RAP-219 Clinical Program

Indeterminate GlobeNewswire

Aug. 24, 2026

Biomea Fusion Announces Completion of Enrollment in COVALENT-211 Phase II Trial of Icovamenib in Insulin-Deficient Type 2 Diabetes

Indeterminate GlobeNewswire

Aug. 24, 2026

InterCure Finalizes NIS 230 Million (~US$77 Million) Settlement for War-Related Indirect Damages

Indeterminate GlobeNewswire

Aug. 24, 2026

Mesoblast Financial Results and Corporate Update Webcast

Indeterminate GlobeNewswire

Aug. 24, 2026

Tiziana Life Sciences Announces Poster Presentation on Phase 2a BANYAN Clinical Trial of Intranasal Foralumab at ALS Nexus 2026

Indeterminate GlobeNewswire

Aug. 24, 2026

ANI Pharmaceuticals Appoints Henry Gosebruch to Board of Directors 

Indeterminate GlobeNewswire

Aug. 24, 2026

WONDERLAB and United Family Healthcare | Global Health Summit 2026

Indeterminate GlobeNewswire

Aug. 24, 2026

A Race Against Blindness Launches New Yukon Denali + Serenova Trailer Fundraiser to Help Cure Childhood Blindness

Indeterminate GlobeNewswire

Aug. 24, 2026

International Case Management Conference Announces Recognised CPD Credits and New Programme Session on Improving Care Transitions

Indeterminate GlobeNewswire

Aug. 24, 2026

NRG Therapeutics Presents Data on Lead Clinical Asset NRG5051 Confirming Novel Disease-Modifying Approach to ALS

Indeterminate GlobeNewswire